Legal & General Group
ALXO icon

Legal & General Group’s ALX Oncology ALXO Stock Holding History

Legal & General Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7K Buy
+10,483
New +$18.8K ﹤0.01% 3083
2025
Q2 		– Sell
-3,860
Closed -$2.4K – 3423
2025
Q1 		$2.4K Hold
3,860
– – ﹤0.01% 3344
2024
Q4 		$6.45K Hold
3,860
– – ﹤0.01% 3315
2024
Q3 		$7.04K Sell
3,860
-22,027
-85% -$81.9K ﹤0.01% 3330
2024
Q2 		$156K Buy
25,887
+8,701
+51% +$107K ﹤0.01% 2697
2024
Q1 		$192K Buy
17,186
+14,897
+651% +$209K ﹤0.01% 2686
2023
Q4 		$34.1K Buy
2,289
+684
+43% +$6.49K ﹤0.01% 2869
2023
Q3 		$7.7K Sell
1,605
-576
-26% -$3.13K ﹤0.01% 3314
2023
Q2 		$16.4K Sell
2,181
-1,083
-33% -$7.09K ﹤0.01% 3195
2023
Q1 		$14.8K Sell
3,264
-3,592
-52% -$27.2K ﹤0.01% 3143
2022
Q4 		$77.3K Hold
6,856
– – ﹤0.01% 2872
2022
Q3 		$65K Buy
6,856
+1,547
+29% +$18K ﹤0.01% 2921
2022
Q2 		$43K Buy
5,309
+1,534
+41% +$16.7K ﹤0.01% 3023
2022
Q1 		$64K Hold
3,775
– – ﹤0.01% 2954
2021
Q4 		$81K Buy
3,775
+33
+0.9% +$1.42K ﹤0.01% 2951
2021
Q3 		$276K Buy
3,742
+1,598
+75% +$107K ﹤0.01% 2583
2021
Q2 		$117K Buy
2,144
+39
+2% +$2.33K ﹤0.01% 2682
2021
Q1 		$155K Buy
2,105
+746
+55% +$58.7K ﹤0.01% 2500
2020
Q4 		$117K Buy
1,359
+289
+27% +$17.4K ﹤0.01% 2541
2020
Q3 		$40K Buy
+1,070
New +$42.1K ﹤0.01% 2763

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Legal & General Group's ALXO Position: Q2 2026 in Review

Legal & General Group opened a new position in ALX Oncology (ALXO) in Q2 2026: 10,483 shares worth $21.7K. The stake represents ﹤0.01% of the portfolio and ranks #3083 among its holdings. This is a return to the name: Legal & General Group previously reported a position in ALXO as recently as Q1 2025.

Legal & General Group first reported a position in ALXO in Q3 2020 and has held it in 20 quarters since. The position peaked at $276K in Q3 2021. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Legal & General Group held 10,483 shares of ALX Oncology worth $21.7K as of Q2 2026.
  • ALX Oncology was a new Legal & General Group position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3083 holding.
  • Legal & General Group first reported a position in ALX Oncology in Q3 2020 and has held it in 20 quarters since.
  • Legal & General Group's ALX Oncology position peaked at $276K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.